Document Classification

Section Type: RESULTS

Text: Besides, the improvement in the treated group was superior to that in the control group in terms of clinical symptoms such as fever, arthralgia and baldness (P < 0. 05, P < 0. 01) ; the negative reversion rate of anti-nuclear antibody (ANA, 51. 3 % vs 28. 1 %), antidouble-stranded DNA (ds-DNA, 53. 6 % vs 26. 1 %), anti- ribonucleoprotein (RNP, 63. 2 % vs 29. 4 %) and circulating immnue complexes (CIC, 63. 2 % vs 29. 4 %, all P < 0. 05) ; lowering of immunoglobulin (for IgG, P < 0. 05 ; IgA, P < 0. 01 ; IgM, P < 0. 01) ; as well as bettering in peripheral blood figure, ESR, CRP, Cr and u-TP/24 h (P < 0. 05 or P < 0. 01).